BRPI0418240A - método para a preparação de uma forma de dosagem sólida de desmopressina - Google Patents

método para a preparação de uma forma de dosagem sólida de desmopressina

Info

Publication number
BRPI0418240A
BRPI0418240A BRPI0418240-5A BRPI0418240A BRPI0418240A BR PI0418240 A BRPI0418240 A BR PI0418240A BR PI0418240 A BRPI0418240 A BR PI0418240A BR PI0418240 A BRPI0418240 A BR PI0418240A
Authority
BR
Brazil
Prior art keywords
solid
dosage form
preparation
desmopressin
preparing
Prior art date
Application number
BRPI0418240-5A
Other languages
English (en)
Inventor
Kristin Wannerberger
Hans Lindner
Lars-Erik Olsson
Ann-Elisabeth Svensson
Lars Anders Ragnar Nilsson
Pascal Rene Olivier Danglas
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34702338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0418240(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US10/746,254 external-priority patent/US7018653B2/en
Priority claimed from EP03029897A external-priority patent/EP1550439B1/en
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of BRPI0418240A publication Critical patent/BRPI0418240A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"MéTODO PARA A PREPARAçãO DE UMA FORMA DE DOSAGEM SóLIDA DE DESMOPRESSINA". A presente invenção refere-se a um novo método para a preparação de uma forma de dosagem sólida de peptídeo efetivo perioral, preferivelmente desmopressina ou seu sal farmaceuticamente aceitável, compreendendo fornecer tal granulado contendo peptídeo adequado para compressão a um comprimido farmaceuticamente aceitável, bem como formas de dosagem sólidas, preferivelmente comprimidos obtidos pelo dito método.
BRPI0418240-5A 2003-12-29 2004-12-28 método para a preparação de uma forma de dosagem sólida de desmopressina BRPI0418240A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/746,254 US7018653B2 (en) 2003-12-29 2003-12-29 Method for preparing solid dosage form of desmopressin
EP03029897A EP1550439B1 (en) 2003-12-29 2003-12-29 Method for preparing a solid dosage form of desmopressin
PCT/EP2004/014781 WO2005063202A2 (en) 2003-12-29 2004-12-28 Method for preparing solid dosage form of desmopressin

Publications (1)

Publication Number Publication Date
BRPI0418240A true BRPI0418240A (pt) 2007-04-17

Family

ID=34702338

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0418240-5A BRPI0418240A (pt) 2003-12-29 2004-12-28 método para a preparação de uma forma de dosagem sólida de desmopressina

Country Status (14)

Country Link
EP (1) EP1699437B1 (pt)
JP (1) JP4763617B2 (pt)
KR (1) KR100870679B1 (pt)
AU (1) AU2004308670B2 (pt)
BR (1) BRPI0418240A (pt)
CA (1) CA2490601C (pt)
DE (1) DE602004010302T2 (pt)
DK (1) DK1699437T3 (pt)
ES (1) ES2295962T3 (pt)
MX (1) MXPA06007507A (pt)
NZ (1) NZ546817A (pt)
PL (1) PL209823B1 (pt)
RU (1) RU2334505C2 (pt)
WO (1) WO2005063202A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1677095A (en) * 1994-01-11 1995-08-01 Alkermes Controlled Therapeutics, Inc. Oral dosage form of desmopressin (ddavp)
NZ278678A (en) * 1994-01-31 1998-03-25 Yamanouchi Pharma Co Ltd Compressed moulded tablet with quick disintegration/dissolution in the mouth, mixture of low and high moldable saccharides as carriers
JP4290792B2 (ja) * 1999-01-11 2009-07-08 カルピス株式会社 造粒物、その製法及びこれを用いた錠剤
JP2002538097A (ja) * 1999-03-03 2002-11-12 イーライ リリー アンド カンパニー 薬学的経口ｅｃｂ処方物および組成物の作製方法
IL160190A0 (en) * 2001-10-15 2004-07-25 Roehm Gmbh Use of copolymer to produce a galenic form containining a peptide or a protein as active agent
PT1501534E (pt) * 2002-05-07 2006-09-29 Ferring Bv Formulacoes farmaceuticas
PT1473029E (pt) * 2003-04-30 2005-05-31 Ferring Bv Forma de dosagem solida compreendendo desmopressina
ATE301990T1 (de) * 2003-07-25 2005-09-15 Ferring Bv Pharmazeutische desmopressin-zubereitung als feste darreichungsform und methode zu ihrer herstellung

Also Published As

Publication number Publication date
WO2005063202A3 (en) 2006-05-18
RU2006120954A (ru) 2008-02-10
CA2490601A1 (en) 2005-06-29
PL381356A1 (pl) 2007-05-28
JP2007517000A (ja) 2007-06-28
MXPA06007507A (es) 2007-01-30
JP4763617B2 (ja) 2011-08-31
EP1699437B1 (en) 2007-11-21
PL209823B1 (pl) 2011-10-31
ES2295962T3 (es) 2008-04-16
NZ546817A (en) 2010-07-30
KR100870679B1 (ko) 2008-11-26
AU2004308670A1 (en) 2005-07-14
DE602004010302T2 (de) 2008-10-16
DK1699437T3 (da) 2007-12-27
EP1699437A2 (en) 2006-09-13
KR20060111566A (ko) 2006-10-27
AU2004308670B2 (en) 2007-08-02
CA2490601C (en) 2006-05-02
WO2005063202A2 (en) 2005-07-14
DE602004010302D1 (de) 2008-01-03
RU2334505C2 (ru) 2008-09-27

Similar Documents

Publication Publication Date Title
CY1126116T1 (el) Φαρμακευτικες συνθεσεις αποτελουμενες απο νιλοτινιμπη
SG135192A1 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
AR109170A2 (es) Esfingomielinasa ácida para uso en la prevención o el tratamiento de la enfermedad de niemann-pick a o b en un paciente
PE20241581A1 (es) Formas cristalinas de un inhibidor de tirosina quinasa de bruton
EA201200937A1 (ru) Твердая лекарственная форма тикагрелора
UY28473A1 (es) Nuevos compuestos
EA200600320A1 (ru) γ-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ
EA200600321A1 (ru) βd-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ
PH12016502103A1 (en) Novel disubstituted 1,2, 4-triazine compound
MX2009004908A (es) Compuestos quimicos.
EA200601662A1 (ru) δ-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ
AR093705A1 (es) Depsipeptido y sus usos
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
MX340188B (es) Elaboracion de granulos sin activos y tabletas que comprenden los mismos.
BRPI0311189B8 (pt) composições farmacêuticas contendo polimorfo a de flibanserin, bem como seu uso
WO2007078895A3 (en) Modified release formulations of tramadol and uses thereof
EA201270573A1 (ru) Гранулированный в расплаве цинакальцет
BRPI0410044A (pt) forma de dosagem contendo pantoprazol como ingrediente ativo
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
BRPI0412905A (pt) composição farmacêutica como forma de dosagem sólida e método de fabricação
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
WO2016066726A3 (en) Active acrylamides
CL2004000984A1 (es) Forma de dosificacion oral de una sal de magnesio de (s)-pantopazol, para la profilaxis o tratamiento de una condicion asociada a inhibir la bomba protonica.
AR047155A1 (es) METODO PARA LA PREPARACION DE UNA FORMA DE DOSIFICACIoN SOLIDA DE DESMOPRESINA
TW200745042A (en) Substituted pyrazoline compounds, their preparation and use as medicaments

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 9A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.